Ebola cases accelerating


The World Health Organization says that the Ebola cases are accelerating. Forty percent of the infections have happened in the last 21 days. More than 20K people may be infected before the outbreak is contained.

Eight companies are working on Ebola vaccines/therapies:

Tekmira Pharmaceuticals (NASDAQ:TKMR): TKM-Ebola in Phase 1; Sarepta Therapeutics (NASDAQ:SRPT): AVI-7537 in Preclinicals; NewLink Genetics (NASDAQ:NLNK): Ebola Vaccine in Preclinicals; BioCryst Pharmaceuticals (NASDAQ:BCRX): BCX4430 in Preclinicals; GlaxoSmithKline (NYSE:GSK): Ebola Vaccine in Preclinicals; Nanoviricides (NYSEMKT:NNVC): NV-INF-1 in Preclinicals; Inovio Pharmaceuticals (NYSEMKT:INO): SynCon DNA Vaccine in Preclinicals; FujiFilm (OTC:FUJIF) (OTCPK:FUJIY): Favipiravir in Preclinicals and Mapp Pharmaceuticals: ZMapp in Preclinicals.

From other sites
Comments (15)
  • kolczan
    , contributor
    Comment (1) | Send Message
     
    i scare of this ebola ;/
    28 Aug 2014, 07:28 AM Reply Like
  • retroaspect
    , contributor
    Comments (15) | Send Message
     
    why? are you not strong men?
    28 Aug 2014, 10:19 AM Reply Like
  • KarinCA
    , contributor
    Comments (534) | Send Message
     
    Read my article to get more information on companies in the ebola space working on treatments and/or vaccines:

     

    Tekmira Pharmaceuticals Is More Than Just A Short-Term Ebola Trade
    http://seekingalpha.co...

     

    You'll find a list of 10 competitors to TKMR in the ebola space.
    28 Aug 2014, 04:57 PM Reply Like
  • dacama1
    , contributor
    Comments (221) | Send Message
     
    Critical Mass?
    28 Aug 2014, 08:45 AM Reply Like
  • Leif Smith
    , contributor
    Comments (11) | Send Message
     
    NanoViricides (NYSEMKT:NNVC) has a novel approach worth knowing about.
    28 Aug 2014, 09:25 AM Reply Like
  • houston37
    , contributor
    Comments (17) | Send Message
     
    TKMR is the company to own for Ebola.
    28 Aug 2014, 10:19 AM Reply Like
  • nomadsam
    , contributor
    Comments (4) | Send Message
     
    I wish Inovio would release a PR regarding this. Since DNA vaccines are relatively easy to manufacture, SynCon seems to be the ideal candidate to deal with the current ebola situation.
    28 Aug 2014, 10:19 AM Reply Like
  • wonder7707
    , contributor
    Comments (7) | Send Message
     
    So which company do you invest in? They all seem to be popping at different times.
    28 Aug 2014, 10:20 AM Reply Like
  • Manitobatex
    , contributor
    Comments (1204) | Send Message
     
    The Canadian Government has agreed to send approx. 800 doses of vaccine that they have produced over two years ago to South Africa and noteworthy is that The Canadian Government is working with the MAPP group to produce a solution.
    CBC News released the news about the shipment to South Africa a week ago or so.
    28 Aug 2014, 01:06 PM Reply Like
  • Notsodumb
    , contributor
    Comments (7) | Send Message
     
    I'm surprised FDA hasn't allowed multiple human trials in Africa on each of the known preclinical vaccines to determine which offers the best cure and protection from the Ebola virus. Inaction by bureaucracy seems to insure increasing needless death rates from this Ebola virus. Inaction equals stupidly, rather than being over-cautious.
    28 Aug 2014, 01:44 PM Reply Like
  • synergistic_serendipity
    , contributor
    Comments (147) | Send Message
     
    I may have missed it, but do we know the treatments provided to the two American docs shipped home? Both recovered......
    28 Aug 2014, 02:40 PM Reply Like
  • paimon
    , contributor
    Comments (4) | Send Message
     
    Dr. Kent Brantly received immune plasma infusion from an Ebola survivor in addition to Zmapp and aggressive monitoring of symptoms--the kitchen sink approach. Zmapp is derived from the serum of chimpanzees infected with a synthetic virus, but it alone is no miracle cure, as one patient receiving it has already died. A statistically provable cure can't happen unless/until a lot more people get sick.

     

    By the way, hasn't everyone seen "12 Monkeys"? All the hospital workers get killed off first, many more die, civilization ends, and even time travelers can't figure out what really happened. We're obviously hoping to avoid that scenario by aggressively treating health-care professionals.

     

    http://bit.ly/1mYQCGd
    http://bit.ly/1mYQCGg
    http://bit.ly/1mYQC92
    28 Aug 2014, 03:43 PM Reply Like
  • Manitobatex
    , contributor
    Comments (1204) | Send Message
     
    cbc.ca/news/Canada/Man...

     

    This will give another avenue to hopefully stop Ebola.
    28 Aug 2014, 03:01 PM Reply Like
  • Kastanes
    , contributor
    Comments (1287) | Send Message
     
    NIH and GSK are going to try a vaccine that is dead and codes for 2 of Ebola's proteins. If GSK was not receiving funding from the NIH, I can guarantee you GSK would not even bother. This vaccine is at best a long shot.

     

    If the NIH wants to get serious, create a live, replication competent, attenuated vaccine. Nearly all effective vaccines use this method.

     

    The FDA and NIH have lost touch with reality.
    28 Aug 2014, 07:02 PM Reply Like
  • Leif Smith
    , contributor
    Comments (11) | Send Message
     
    http://nanoviricides.com — Can this technology avoid the continual mutation problem?
    29 Aug 2014, 10:20 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs